Purchase Order AG5522P160011
Award Date 8/3/16
Potential Completion Date 8/4/17
Potential Value $57K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Illumina, Inc., a San Diego-based biotechnology company specializing in genomic sequencing and analysis technologies, was awarded a Purchase Order contract by the Office of Administrative Services Procurement Management Branch on April 7, 2015, with a ceiling value of $29,529.80 and an ultimate completion date of April 30, 2016. This Firm Fixed Price contract, which carries no set-aside designation, is to be performed in Athens, Georgia. As a leading provider of DNA and RNA sequencing...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, received a contract award on March 20, 2018, through a Blanket Purchase Agreement (BPA) call with a civilian federal agency's Southeast Area office. The contract, valued at $8,256.23 with a firm fixed price structure, covers the procurement of Nextera XT DNA Library Preparation Kit, Index Kit, High Output Kit, and PhiX Control Kit—specialized reagent kits essential for...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, received a delivery order from a civilian federal agency's Northeast Area office for Illumina reagent kits valued at $39,121.64. This firm fixed-price contract, awarded on May 3, 2024, with a completion date of December 31, 2024, will be performed in Orient, New York. The delivery order procures laboratory equipment, consumables, and services without a set-aside...
- Illumina, Inc. was awarded a contract valued at $421,838.22 by the Office of Administrative Services Procurement Management Branch to supply Illumina sequencing equipment and related products for the Eastern Laboratory. This contract is executed as a call order under the existing Blanket Purchase Agreement AG-32SC-B-14-0005 on a firm fixed-price basis with no set-aside designation. The award was made on January 9, 2019, with an ultimate completion date of September 9, 2019, and performance is...
- Illumina, Inc. was awarded a purchase order by a civilian federal agency for genomic sequencing reagents and consumables valued at $23,623.39. The contract, awarded on December 17, 2018, with an ultimate completion date of December 26, 2018, procures five specific product lines including TruSeq DNA Single Indexes Sets A and B, TruSeq DNA PCR-Free Low Throughput Library Prep Kit, NextSeq 500/550 High Output Kit v2.5, and MiSeq Reagent Kit v2. These products represent core components of Illumina's...
- Illumina, Inc. was awarded a $133,049.98 Firm Fixed Price Blanket Purchase Agreement (BPA) call for NeoPrepLibrary and MiSeq Systems on July 8, 2015, with a completion date of August 8, 2015. The contract, which carried no set-aside designation, was issued by the Plains Area civilian agency and calls for delivery to Illumina's headquarters location in San Diego, California. This award represents a task order against an existing BPA vehicle, reflecting the government's established procurement...
- Illumina, Inc. was awarded a $15,844.61 firm fixed price call under a Blanket Purchase Agreement (BPA) by a civilian federal agency with Midwest Area operations on November 8, 2016, with an ultimate completion date of September 9, 2019. The award covers a Nextera Library Prep Kit, a specialized reagent product used in genomic DNA and RNA sequencing workflows. The contract was performed in San Diego, California, where Illumina maintains its headquarters, and no set-aside designation was applied...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a Blanket Purchase Agreement (BPA) call valued at $49,428.29 for reagents for sequencing under a civilian federal agency's Northeast Area division. The contract, issued on September 30, 2016, with an ultimate completion date of October 29, 2019, utilized a firm fixed-price structure with no set-aside designation. This award reflects Illumina's specialized...
- This is a firm fixed-price delivery order awarded by the Office of the Chief Operating Officer, a civilian agency, to Illumina, Inc. for the NeoPrep Library Prep System. The contract has a ceiling value of $51,466.66 and a completion date of August 31, 2015. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents, and has provided similar goods and services to support research and diagnostic programs across federal agencies like the NIH, CDC, USDA, and VA. This...
- Illumina, Inc. was awarded a delivery order valued at $12,582.81 on September 18, 2024, for Illumina sequencing supplies including DNA preparation kits, MiSeq reagent kit V3, and DNA indexes. This firm fixed-price delivery order, with an ultimate completion date of May 25, 2025, is being performed in San Diego, California and funded by a civilian federal agency in the Northeast Area. The contract carries no set-aside designation, reflecting Illumina's specialized position as a proprietary...